For more information on this report, please reach us at:
GLOBAL CARDIAC PROSTHETIC DEVICES –MARKET GROWTH ANALYSIS, 2009-2015
REPORT CODE: ARMMR121 PUBLISHED: FEBRUARY, 2011 REPORT PRICE: $3270
The report ‘
Global Cardiac Prosthetic Devices - Market Growth Analysis, 2009-2015
’ reviews the latesttrends in cardiac prosthetic devices with a perceptive attempt to disclose the near-future growth prospects.An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sectorinvestments. The study reveals profitable investment strategies for pharmaceutical manufacturers,biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizationsand many more in preferred locations.Estimates are based on online surveys using customized questionnaires by our research team. Besidesinformation from government databases, company websites, press releases & published research reports arealso used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry.Anticipating a protracted recovery towards 2011, we have used CAGR to forecast 2011-2015 figures.More than 608 leading market players are identified and 82 key companies in cardiac medical devicesindustry that project improved market activities in the near future are profiled. The report consists of 115data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategicactivities in the market including mergers/acquisitions, collaborations/partnerships, productlaunches/developments are discussed.
Global market watch
The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varyingfrom sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in thehealth care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years,confirms the positive growth prospects going ahead.Global cardiac prosthetic devices market forecasts to reach at US$2.9 billion by 2015 at a CAGR of 9.5%during the analysis period 2009-2015. The North American segment accounts for approximately 40% of theglobal value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing regionwith a CAGR of 10.5% driving a market value of US$0.5 billion by 2015. Among the product types, mechanicalheart valves account more nearly half of the market value while tissue and transcatheter segments add up tothe remaining half. On a global scale, CAGR projections for tissue heart valves market indicate a double digitvalue, indicative of an improved investment returns in the upcoming years.
C o p y r i g h t © 2 0 1 1 | A x i s R e s e a r c h M i n d | A l l R i g h t s R e s e r v e d
“GETTING THE MOST FROM OUR RESEARCH ANALYSIS”